检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).

Haruka Maeda,Nobuo Saito,Ataru Igarashi,Masayuki Ishida,Mayumi Terada, Takayasu Ito, Hideko Ikeda,Hiroshi Kamura,Iori Motohashi,Yuya Kimura,Masaru Komino,Hiromi Arai,Osamu Kuwamitsu,Nobuhiro Akuzawa,Eiichiro Sando,Toru Morikawa,Haruki Imura, Hiroki Inoue,Tomoichiro Hayakawa,Osamu Teshigahara,Yasuji Ohara,Motoi Suzuki,Konosuke Morimoto

Expert review of vaccines（2023）

引用 0|浏览14
暂无评分
摘要
During BA.1 and BA.2 epidemic in Japan, mRNA COVID-19 primary vaccination provided modest protection. Booster vaccination was necessary to protect against symptomatic infections.
更多
查看译文
关键词
BA.1,BA.2,COVID19,Japan,SARSCoV2,omicron,vaccine effectiveness
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要